Literature DB >> 9840023

Preparation of slightly hydrophobic heparin derivatives which can be used for solvent casting in polymeric formulation.

Y Lee1, H T Moon, Y Byun.   

Abstract

Heparin is clinically administered mainly by intravenous injection because of its highly hydrophilic property. A slightly hydrophobic heparin derivative which can be dissolved in organic solvent can be widely used in polymeric devices for clinical applications. In this study, hydrophobic heparin derivatives were prepared by coupling heparin with deoxycholic acid, cholesterol, lauric acid, and palmitic acid, respectively. The hydrophobicity of these heparin derivatives depended on the feed mole ratio of heparin to hydrophobic agents, and they showed good solubility in the co-solvent of acetone and water, as well as in water alone. Also, these heparin derivatives showed high anticoagulant activity. This approach for preparing hydrophobic heparin is expected to advance the drug delivery system by further extending the applications of heparin to medical devices such as cardiopulmonary bypass circuits, heart lung oxygenators, and kidney dialyzers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9840023     DOI: 10.1016/s0049-3848(98)00124-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Oral delivery of new heparin derivatives in rats.

Authors:  Y Lee; S H Kim; Y Byun
Journal:  Pharm Res       Date:  2000-10       Impact factor: 4.200

2.  Antiangiogenic effect of bile acid acylated heparin derivative.

Authors:  Kyeongsoon Park; Yoo-Shin Kim; Gee Young Lee; Ju-Ock Nam; Seok Ki Lee; Rang-Woon Park; Sang Yoon Kim; In-San Kim; Youngro Byun
Journal:  Pharm Res       Date:  2006-11-16       Impact factor: 4.200

3.  Antiangiogenic and apoptotic properties of a novel amphiphilic folate-heparin-lithocholate derivative having cellular internality for cancer therapy.

Authors:  Mi Kyung Yu; Dong Yun Lee; Yoo Shin Kim; Kyeongsoon Park; Soo Ah Park; Dai Hyun Son; Gee Young Lee; Jong Hee Nam; Sang Yoon Kim; In San Kim; Rang Woon Park; Youngro Byun
Journal:  Pharm Res       Date:  2007-02-21       Impact factor: 4.200

4.  Synthesis and evaluation of amphiphilic RGD derivatives: uses for solvent casting in polymers and tissue engineering applications.

Authors:  A G Kidane; H J Salacinski; G Punshon; B Ramesh; K S Srai; A M Seifalian
Journal:  Med Biol Eng Comput       Date:  2003-11       Impact factor: 2.602

5.  Tumor endothelial cell targeted cyclic RGD-modified heparin derivative: inhibition of angiogenesis and tumor growth.

Authors:  Kyeongsoon Park; Yoo-Shin Kim; Gee Young Lee; Rang-Woon Park; In-San Kim; Sang Yoon Kim; Youngro Byun
Journal:  Pharm Res       Date:  2008-06-26       Impact factor: 4.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.